Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma

References

• Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma. 2014 Appendices Available from: http://www.ginasthma.org/local/uploads/content/files/GINA_Appendix_2014_Jun11.pdfAccessed December 10, 2014
   Google Scholar
• Centers for Disease Control and PreventionSurvey reveals growing national impact of asthma Available from: http://www.cdc.gov/media/releases/2012/p0515_asthma_impact.htmlAccessed December 10, 2014
   Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention2014 Available from: http://www.ginasthma.org/Accessed December 10, 2014
   Google Scholar
• Expert Panel Report 3. Guidelines for the diagnosis and management of asthma Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdfAccessed December 10, 2014
   Google Scholar
• CazzolaMPageCPCalzettaLMateraMGPharmacology and therapeutics of bronchodilatorsPharmacol Rev20126445050422611179
   PubMed Web of Science ®Google Scholar
• HorneRPriceDClelandJCan asthma control be improved by understanding the patient’s perspective?BMC Pulm Med20077817518999
   PubMedGoogle Scholar
• BouletLPVervloetDMagarYFosterJMAdherence: the goal to control asthmaClin Chest Med20123340541722929091
   PubMed Web of Science ®Google Scholar
• FischerMAChoudhryNKBrillGTrouble getting started; predictors of primary medication nonadherenceAm J Med20111241081.e91081.e2222017787
   PubMed Web of Science ®Google Scholar
• MoonieSAStrunkRCCrockerSCurtisVSchechtmanKCastroMCommunity asthma program improves appropriate prescribing in moderate to severe asthmaJ Asthma20054228128916032937
   PubMed Web of Science ®Google Scholar
• Healthy People 2020Respiratory diseases Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=36Accessed December 10, 2014
   Google Scholar
• WalkerJWinkelsteinMLandCFactors that influence quality of life in rural children with asthma and their parentsJ Pediatr Health Care20082234335018971080
   PubMed Web of Science ®Google Scholar
• PharmaTimes DigitalSkyePharma’s Flutiform finally gets EU ‘yes’ Available from: http://www.pharmatimes.com/Article/12-07-04/SkyePharma_s_Flutiform_finally_gets_EU_yes.aspxAccessed December 10, 2014
   Google Scholar
• PMLiveSuccessful partnerships in pharma: Skyepharma and Mundipharma Available from: http://www.pmlive.com/pharma_news/successful_partnerships_in_pharma_skyepharma_and_mundipharma_606751Accessed December 10, 2014
   Google Scholar
• Skypharma.comFlutiform marketing Available from: http://www.skyepharma.com/Products/Inhalation_products/Approved_inhalation_products/Flutiform_marketing/Default.aspx?id=72Accessed December 9, 2014
   Google Scholar
• Facts and ComparisonseAnswers Available from: http://online.factsandcomparisons.com/MonoDisp.aspx?monoID=fandc-hcp12879&quick=650717%7c5&search=650717%7c5&isstemmed=True&NDCmapping=−1&fromTop=true#firstMatchAccessed December 10, 2014
   Google Scholar
• LipworthBJSystemic adverse effects of inhaled corticosteroids: a systematic review and meta-analysisArch Intern Med199915994195510326936
   PubMed Web of Science ®Google Scholar
• RolandNJBhallaRKEarisJThe local side effects of inhaled corticosteroids. Current understanding and review of the literatureChest200412621321915249465
   PubMed Web of Science ®Google Scholar
• Facts and ComparisonseAnswers Available from: http://online.factsandcomparisons.com/MonoDisp.aspx?monoid=fandc-hcp12443&book=DFC&fromtop=true&search=375422%7c5&isStemmed=True&asbooks=Accessed December 10, 2014
   Google Scholar
• CorrenJMansfieldLEPertsevaTBlahzkoVKaiserKEfficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthmaRespir Med201310710895
   Web of Science ®Google Scholar
• Bodzenta-LukaszykAPulkaGDymekAEfficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhalerRespir Med201110567468221196104
   PubMed Web of Science ®Google Scholar
• Bodzenta-LukaszykAvan NoordJSchroder-BaboWMcAulayKMcIverTEfficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomized controlled trialCurr Med Res Opin20132957958823368897
   PubMed Web of Science ®Google Scholar
• NathanRAD’UrzoABlazhkoVKaiserKSafety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomized controlled trialBMC Pulm Med201212678223078148
   PubMed Web of Science ®Google Scholar
• PearlmanDSLaForceCFKaiserKFluticasone/formoterol combination therapy compared to monotherapy in adolescent and adult patients with mild to moderate asthmaClin Ther20133595096623870606
   PubMed Web of Science ®Google Scholar
• PertsevaTDissanayakeSKaiserKSuperiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomized controlled trialCurr Med Res Opin2013291357136923865726
   PubMed Web of Science ®Google Scholar
• DissanayakeSGrotheBKaiserKFluticasone/formoterol: a new single-aerosol combination therapy for patients with asthmaRespir Med2012106520528
   Web of Science ®Google Scholar
• MansurAHKaiserKLong-term safety and efficacy of fluticasone/formoterol combination therapy in asthmaJ Aerosol Med Pulm Drug Deliv20132619019923098325
   PubMed Web of Science ®Google Scholar
• Bodzenta-LukaszykADyrnekAMcAulayKMansikkaHFluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized studyBMC Pulm Med201111283821605396
   PubMed Web of Science ®Google Scholar
• AalbersRBrusselleGMcIverTGrotheBBodzenta-LukasykAOnset of bronchodilation with fluticasone-formoterol combination versus fluticasone-salmeterol in an open-label, randomized studyAdv Ther20122995896923081745
   PubMed Web of Science ®Google Scholar
• Bodzenta-LukasykBuhlRBalintBLomaxMSpoonerKDissanayakeSFluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trail of efficacy and safetyJ Asthma2012491060107023102189
   PubMedGoogle Scholar
• KramerJMBalancing the benefits and risks of inhaled long-acting beta-agonists – the influence of valuesN Engl J Med20093601592159519369665
   PubMed Web of Science ®Google Scholar
• ChowdhuryBAPanGDThe FDA and safe use of long-acting beta-agonists in the treatment of asthmaN Engl J Med20103621169117120181964
   PubMed Web of Science ®Google Scholar
• BrozekJLKraftMKrishnanJALong-acting β2-agonist step-off in patients with controlled asthma. Systematic review with meta-analysisArch Intern Med201217213631373
   Google Scholar
• National Institute for Health and Care ExcellenceEvidence summary Available from: http://www.nice.org.uk/advice/esnm3Accessed November 18, 2014
   Google Scholar
• Napp Pharmaceuticals LtdFlutiform^® package insert Available from: https://www.medicines.org.uk/emc/PIL.26957.latest.pdfAccessed December 10, 2014
   Google Scholar
• DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelinesChest200512733537115654001
   PubMed Web of Science ®Google Scholar
• SkypharmaAnnual Report and Accounts 2013 Available from: http://www.skyepharma.com/Doc/02_PDF/01_FINANCIAL%20INFORMATION/2013%20Annual%20Report.pdfAccessed December 10, 2014
   Google Scholar